Bubs Australia is preparing to have a third and fourth US-issued plane to airlift 180,000 tins of its infant formula across the Pacific Ocean in coming weeks, while rival A2 Milk waits for its application to be approved by the US authorities.
The Biden administration, which has already airlifted two planes full of the goat milk formula, will issue another two to pick up a total of 180,465 tins of Bubs’ product in two batches. The first plane will touch down in Los Angeles on June 26 and the second plane will arrive at Philadelphia on July 5.
Bubs founder Kristy Carr.Credit:James Brickwood
The 180,000 tins are part of the 1.25 million tins initially announced by Bubs late last month and form Amercia’s ninth ‘Operation Fly Formula’ mission as President Joe Biden strikes deals with several global manufacturers to patch its baby formula shortage.
Bubs Australia has already sent two planes of its goat milk-made baby formula to the US, which have been purchased and distributed by US retailers Walmart, Alberstons (Safeway), and Kroger Co.
Bubs Australia chief Kristy Carr said it was “immensely rewarding” that Bubs’ products were on American supermarket shelves less than a month after the US FDA granted approval for the formula maker to import its product.
“By mid-July we expect 361,299 cans of Bubs Infant Formula to have been made available to major retailers across 34 states. This reflects an incredibly concerted effort,” Carr said.
Earlier this week, Carr and executive chairman Dennis Lin met with health and human services administration officials at the White House in “wide-ranging discussions” about the “ongoing collaboration” between the ASX-listed company and the US government.
“It was a pleasure to meet with the team at the executive office of the president in person to discuss Operation Fly Formula and Bubs Australia’s long-term commitment to support American families,” Carr said.
Bubs’ share price has jumped at the news, rising 3.23 per cent to 64 cents at 11.30am AEST.
Meanwhile, an A2 Milk spokesperson confirmed the dairy giant was still waiting for its initial application to be approved by the US Food and Drug Administration (FDA).
The Business Briefing newsletter delivers major stories, exclusive coverage and expert opinion. Sign up to get it every weekday morning.
Most Viewed in Business
From our partners
Source: Read Full Article